Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 29, 2025.

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q1 CY2025, with ...

This edition of Org Chart has news on a number of centers around campus, as well as a new endowed chair, a key financial ...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results , with sales up 12.1% year on year to ...

Diversified science and technology company Danaher (NYSE:DHR) reported Q1 CY2025 results , but sales were flat year on year ...

Johnson & Johnson (J&J) has reported its first-quarter 2025 results, showcasing a 2.4% increase in reported sales to $21.9 billion, with operational growth at 4.2% and adjusted operational growth at 3 ...

Duato pointed, in particular, to Johnson & Johnson's recent announcement that it would invest more than $55 billion in the U.S. over the next four years toward manufacturing, research and technology.

Johnson & Johnson JNJ reported 2.4% sales growth (2.3% in innovative medicine, 2.5% in medtech) and 2.2% adjusted EPS growth ...

Discover insights from Johnson & Johnson's Q1 2025 earnings call, highlighting 4.2% sales growth, MedTech innovation, and strategies to offset ...

Innovative Medicine sales increased 2.3% or 4.2 operationally to $ ... and consensus of $90.62 billion The Medtech giant expects 2025 adjusted operational EPS of $10.50-$10.70, compared to prior ...

Johnson & Johnson (NYSE: JNJ) is set to report its first-quarter earnings on Tuesday, April 15th, before the market opens, ...

There needs to be a passage of time for characters to have absorbed this experience and then have it manifest itself however ...